Business
Inherited Retinal Disease Market Analysis Report 2025-2035, Featuring Profiles of Novartis, GenSight Biologics, Aldeyra Therapeutics, and Spark Therapeutics
The global inherited retinal disease market is poised for significant growth by 2025, driven by increasing prevalence of retinal conditions and advancements in genetic and cell-based therapies. Key diseases include retinitis pigmentosa, Leber congenital amaurosis, and Stargardt disease, which lead to progressive vision loss. Gene therapies and stem cell treatments are transforming the market alongside precision medicine advancements. While cost remains a barrier, emerging markets and regenerativ
About this update from Gensight Biologics Sa
[{"type":"image","alt":"Company Logo","displaySize":"","headline":null,"caption":"Company Logo","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":36,"url":"https://media.zenfs.com/en/globenewswire.com/6a90a26a88cc04ec0d3fe15e0ab1be65"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/g_3H8YP5.WdAX5cBtX03VA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTUwO2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/6a90a26a88cc04ec0d3fe15e0ab1be65","width":300,"height":36}},"lazy":false},{"type":"text","content":"The global inherited retinal disease market is poised for significant growth by 2025, driven by increasing prevalence of retinal conditions and advancements in genetic and cell-based therapies. Key diseases include retinitis pigmentosa, Leber congenital amaurosis, and Stargardt disease, which lead to progressive vision loss. Gene therapies and stem cell treatments are transforming the market alongside precision medicine advancements. While cost remains a barrier, emerging markets and regenerative solutions offer growth opportunities. North America leads the market, with rapid growth expected in Asia-Pacific. Leading companies like Novartis and Spark Therapeutics are pioneering innovations.","length":698,"tagName":"p"},{"type":"text","content":"Dublin, Nov. 19, 2025 (GLOBE NEWSWIRE) -- The "Inherited Retinal Disease Market - A Global and Regional Analysis: Focus on Country and Region - Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's offering.The global inherited retinal disease market is projected to experience significant growth, reaching substantial valuation in 2025, with an expected steady compound annual growth rate (CAGR) during the forecast period from 2025 to 2035.","length":489,"tagName":"p"},{"type":"text","content":"This growth is driven by the rising prevalence of retinal diseases and advancements in genetic and cell-based therapies. Inherited retinal diseases, including retinitis pigmentosa, Leber congenital amaurosis, and Stargardt disease, are progressive genetic disorders that lead to vision loss. With the advent of gene therapies and stem cell treatments, the market for inherited retinal disease treatments is set to undergo a transformation.The growing emphasis on precision medicine, which tailors treatments to individual genetic mutations, is also a major dri...